John was a consultant in metabolic disorders in the UK’s National Health Service and transferred to the MHRA(UK) in 2007 where he now assesses advanced therapy medicinal products in the Biologicals Unit.
John has published on several aspects of metabolic disorders; more recently he has published on the challenges of personalised medicine being faced by current legislation.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.